These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32260077)

  • 1. Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
    Khan T; He Y; Kryza T; Harrington BS; Gunter JH; Sullivan MA; Cuda T; Rogers R; Davies CM; Broomfield A; Gough M; Wu AC; McGann T; Weroha SJ; Haluska P; Forbes JM; Armes JE; Barry SC; Coward JI; Jagasia N; Chetty N; Snell CE; Lourie R; Perrin LC; Hooper JD
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
    He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
    Oncogene; 2016 Jan; 35(4):468-78. PubMed ID: 25893298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
    Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
    Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal chemotherapy treatment for women with recurrent ovarian cancer.
    Fung-Kee-Fung M; Oliver T; Elit L; Oza A; Hirte HW; Bryson P
    Curr Oncol; 2007 Oct; 14(5):195-208. PubMed ID: 17938703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
    Sasaki K; Nishina S; Yamauchi A; Fukuda K; Hara Y; Yamamura M; Egashira K; Hino K
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):739-762. PubMed ID: 33191170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
    Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
    Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
    Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
    Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers.
    Singh T; Neal A; Dibernardo G; Raheseparian N; Moatamed NA; Memarzadeh S
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35191515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress.
    Yamada M; Tomida A; Yun J; Cai B; Yoshikawa H; Taketani Y; Tsuruo T
    Cancer Chemother Pharmacol; 1999; 44(1):59-64. PubMed ID: 10367750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
    Sobhakumari A; Orcutt KP; Love-Homan L; Kowalski CE; Parsons AD; Knudson CM; Simons AL
    Oncol Res; 2016; 24(1):55-64. PubMed ID: 27178822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A; Bokemeyer C; Scharnofkse M; Hapke G; Reile D; Schmoll HJ
    Cancer Chemother Pharmacol; 1993; 33(1):43-7. PubMed ID: 8269588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
    Kreitzburg KM; Fehling SC; Landen CN; Gamblin TL; Vance RB; Arend RC; Katre AA; Oliver PG; van Waardenburg RCAM; Alvarez RD; Yoon KJ
    Cancer Lett; 2018 Nov; 436():75-86. PubMed ID: 30120964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
    Yamashita Y; Akatsuka S; Shinjo K; Yatabe Y; Kobayashi H; Seko H; Kajiyama H; Kikkawa F; Takahashi T; Toyokuni S
    PLoS One; 2013; 8(3):e57724. PubMed ID: 23469222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer.
    Ngoi NY; Syn NL; Goh RM; Goh BC; Huang RY; Soon YY; James E; Cook A; Clamp A; Tan DS
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD012007. PubMed ID: 35188221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel actions of 2-deoxy-D-glucose: protection against Shiga toxins and changes in cellular lipids.
    Kavaliauskiene S; Skotland T; Sylvänne T; Simolin H; Klokk TI; Torgersen ML; Lingelem AB; Simm R; Ekroos K; Sandvig K
    Biochem J; 2015 Aug; 470(1):23-37. PubMed ID: 26251444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
    Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effect of 2-deoxy-D-glucose on glycoprotein mannosylation in cancer cells.
    Ahadova A; Gebert J; von Knebel Doeberitz M; Kopitz J; Kloor M
    IUBMB Life; 2015 Mar; 67(3):218-26. PubMed ID: 25854316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of selenium plus chemotherapy in gynecologic cancers.
    Song M; Kumaran MN; Gounder M; Gibbon DG; Nieves-Neira W; Vaidya A; Hellmann M; Kane MP; Buckley B; Shih W; Caffrey PB; Frenkel GD; Rodriguez-Rodriguez L
    Gynecol Oncol; 2018 Sep; 150(3):478-486. PubMed ID: 30068487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.
    Thibault B; Jean-Claude B
    J Ovarian Res; 2017 Apr; 10(1):31. PubMed ID: 28446239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.